restrictions may preclude administration of high-dose or adjuvanted influenza vaccination to patients <65 years of age. High-dose influenza vaccine is a quadrivalent vaccine containing 4 times the antigen as the standard-dose vaccine. Two RCTs in rheumatoid arthritis (RA) patients showed higher seroconversion rates in younger patients receiving high-dose vaccination compared to standard-dose vaccination with no safety signal Pneumococcal vaccination For patients with RMD age <65 years who are